Haemonetics Corp (HAE) (Q2 2027) Earnings Call Highlights: Raised Guidance and Expanded CSL ...
Haemonetics Corp (HAE) lifted fiscal 2027 revenue guidance on 10% organic growth and a landmark CSL deal, even as transitory costs trimmed operating margin expectations. Related Stocks: HAE ,